HDAX Therapeutics
HDAX Therapeutics is a preclinical stage company developing next-gen (2-site binding) small molecule therapeutics for diseases stemming from microtubule dysfunction.
HDAX Therapeutics operates in advanced therapies based in United States.
Within the advanced therapies space, the company focuses on its core offering rather than a broad product line.
The business is associated with United States.
The company is listed at the Creative Destruction Lab alumni company stage of development.
| Sector | Advanced Therapies |
|---|---|
| Country | United States |
| Stage | Creative Destruction Lab alumni company |
Website: hdaxtx.com
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account